CVS Health Corp (CVS)
Cash ratio
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and cash equivalents | US$ in thousands | 8,586,000 | 6,875,000 | 12,507,000 | 9,801,000 | 8,196,000 | 13,043,000 | 13,807,000 | 14,618,000 | 12,945,000 | 17,197,000 | 12,116,000 | 8,442,000 | 9,408,000 | 9,826,000 | 7,119,000 | 5,598,000 | 7,854,000 | 9,256,000 | 14,869,000 | 10,081,000 |
| Short-term investments | US$ in thousands | 2,407,000 | 2,805,000 | 3,755,000 | 3,288,000 | 3,259,000 | 3,145,000 | 3,080,000 | 3,102,000 | 2,778,000 | 2,792,000 | 2,877,000 | 2,900,000 | 3,117,000 | 3,015,000 | 3,006,000 | 3,190,000 | 3,000,000 | 2,831,000 | 2,596,000 | 2,632,000 |
| Total current liabilities | US$ in thousands | 84,609,000 | 84,627,000 | 81,386,000 | 83,319,000 | 79,189,000 | 81,553,000 | 79,206,000 | 75,054,000 | 69,421,000 | 72,409,000 | 68,457,000 | 69,780,000 | 67,807,000 | 64,709,000 | 59,311,000 | 60,104,000 | 62,017,000 | 62,044,000 | 63,694,000 | 59,560,000 |
| Cash ratio | 0.13 | 0.11 | 0.20 | 0.16 | 0.14 | 0.20 | 0.21 | 0.24 | 0.23 | 0.28 | 0.22 | 0.16 | 0.18 | 0.20 | 0.17 | 0.15 | 0.18 | 0.19 | 0.27 | 0.21 |
December 31, 2024 calculation
Cash ratio = (Cash and cash equivalents + Short-term investments) ÷ Total current liabilities
= ($8,586,000K
+ $2,407,000K)
÷ $84,609,000K
= 0.13
The cash ratio of CVS Health Corp has shown fluctuations over the period from March 31, 2020, to December 31, 2024. The cash ratio, a liquidity ratio that indicates a company's ability to cover its short-term obligations using its cash and cash equivalents, ranged from a low of 0.11 on September 30, 2024, to a high of 0.28 on September 30, 2022.
Overall, the cash ratio remained relatively stable during the early part of the period, hovering around the 0.20 mark. However, towards the end of the period, there was some variability in the ratio, with a noticeable decline in the last quarter of 2023 and the first quarter of 2024.
This fluctuation in the cash ratio suggests varying levels of liquidity for CVS Health Corp during this period. It is important for investors and stakeholders to closely monitor the cash ratio to assess the company's ability to meet its short-term financial obligations using its cash reserves.
Peer comparison
Dec 31, 2024